Announcements Trials
Browse Landscape

Status

Completed 28Unknown 17Recruiting 11Active not recruiting 7Terminated 5Not yet recruiting 4Withdrawn 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Meningioma 1Glioma 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Hematologic Tests × Clear all
NCT01838265 2014-12-08

MGM

University of Miami

Withdrawn
Genitourinary

Prostatic Neoplasms

NCT00985036 2012-04-24

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Marquette General Health System

Withdrawn
CNS

Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡